CD8A and retinopathy of prematurity: Our study indicates that AVR-123 NP eyedrops have no visually observable side effects in mouse eyes and are productive in reducing both vaso-obliteration and angiogenesis, along with cytotoxic CD8+ T cells, neutrophils, macrophages, immune cell types, and cytokines that cause inflammation exacerbating the ROP pathology.